Greene Cristóbal, Droppelmann Guillermo, García Nicolás, Jorquera Carlos, Rosales Julio
Clínica MEDS, Santiago, Chile.
Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.
Orthop Res Rev. 2025 Jun 10;17:229-240. doi: 10.2147/ORR.S492591. eCollection 2025.
The lacertus fibrosus serves as a site of entrapment for the proximal median nerve. Traditionally, surgical intervention has been the preferred method for resolution. This study demonstrates that perineural corticosteroid injection of the proximal median nerve entrapment under ultrasound guidance can improve nerve compression, strength, and pain in patients with lacertus fibrosus syndrome (LFS).
A retrospective quasi-experimental cohort study without a control group following the STROBE guidelines was conducted from July 2020 to May 2023. The patient selection was carried out considering Elisabet Hagert's diagnostic criteria. Ultrasound-guided proximal perineural corticosteroid injections were administered in the region of the lacertus fibrosus. Contingency tables were constructed to compare pre-and post-intervention data. The McNemar test was performed to evaluate the differences. Odds ratios (with 95% CI) were calculated to estimate the likelihood of improvement. A level of less than 0.05 was considered statistically significant. All analyses were performed using the R program.
Twenty-four patients with LFS (61% female, median age: 36 years), were analyzed. Significant improvements were observed in muscle strength perception for the flexor carpi radialis [OR: 33.0, 95% CI: 24.95-41.0; p < 0.001], index flexor digitorum profundus [OR: 37.0, 95% CI: 29.0-45.0; p < 0.001], and flexor pollicis longus [OR: 39.0, 95% CI: 31.0-45.0; p < 0.001]. The scratch test positivity significantly decreased [OR: 4.56, 95% CI: 1.94-15.67; p < 0.001], and pain levels were notably reduced [OR: 2.33, 95% CI: 0.97-5.63; p < 0.001].
Perineural corticosteroid injection under ultrasound guidance proved to be a minimally invasive approach for managing LFS. The intervention significantly improves muscle strength perception and reduces nerve compression and pain. These findings underscore the potential of this technique as a viable option for patients who have exhausted other therapeutic approaches before considering surgery.
III cohort, treatment study.
肱二头肌腱膜是正中神经近端的卡压部位。传统上,手术干预一直是首选的解决方法。本研究表明,在超声引导下对正中神经近端卡压进行神经周围皮质类固醇注射可改善肱二头肌腱膜综合征(LFS)患者的神经压迫、力量和疼痛。
按照STROBE指南,于2020年7月至2023年5月进行了一项无对照组的回顾性准实验队列研究。根据伊丽莎白·哈格特的诊断标准进行患者选择。在肱二头肌腱膜区域进行超声引导下的近端神经周围皮质类固醇注射。构建列联表以比较干预前后的数据。进行McNemar检验以评估差异。计算优势比(95%置信区间)以估计改善的可能性。P值小于0.05被认为具有统计学意义。所有分析均使用R程序进行。
分析了24例LFS患者(61%为女性,中位年龄:36岁)。桡侧腕屈肌的肌肉力量感知有显著改善[优势比:33.0,95%置信区间:24.95 - 41.0;P < 0.001],示指深屈肌[优势比:37.0,95%置信区间:29.0 - 45.0;P < 0.001],以及拇长屈肌[优势比:39.0,95%置信区间:31.0 - 45.0;P < 0.001]。划痕试验阳性率显著降低[优势比:4.56,95%置信区间:1.94 - 15.67;P < 0.001],疼痛程度明显减轻[优势比:2.33,95%置信区间:0.97 - 5.63;P < 0.001]。
超声引导下的神经周围皮质类固醇注射被证明是治疗LFS的一种微创方法。该干预显著改善了肌肉力量感知,减轻了神经压迫和疼痛。这些发现强调了该技术对于在考虑手术前已用尽其他治疗方法的患者而言是一种可行选择的潜力。
III级队列,治疗研究。